glp-1 and eye disease Drugs Diabetic Disease: Ozempic, Semaglutide, and Retinopathy Risk GLP-1 drugs may be linked
Description
1 reason people are taking or considering taking GLP-1 medications, followed by diabetes
Bariatric medicine specialists at the University of Missouri Health Care note the absence of rigorous scientific data supporting microdosing effectiveness
These trials showed that semaglutide resulted in an average body weight reduction ranging from 8.4% up to 17% from baseline weight among participants
Another DPP4 inhibitor Des-fluoro-sitagliptin was also reported to decrease the accumulation of M1 macrophages in Gck +/- mice, a -cellspecific glucokinase haploinsufficient (Gck+/) diabetic model (33)
